Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Exicure, Inc. (XCUR): Strategic Equity Financing and Operational Restructuring Signal a...
Exicure, Inc. (NASDAQ: XCUR) has embarked on a critical journey of recovery and transformation, with significant equity financing deals and strategic restructuring...
